Profil bibliographique

Valerie Nicolas‐Métral

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées

1332Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Fibroblast Growth Factor ResearchAntimicrobial Resistance in StaphylococcusEosinophilic Disorders and SyndromesCancer, Hypoxia, and MetabolismKruppel-like factors research

Publications récentes

Accès ouvert 2026 articleOpenAlex

Model-based quantification of immune response and anti-staphylococcal activity of afabicin in immunocompetent mouse thigh infections to enable predictions of clinical efficacy

R. Saporta, Elisabet I. Nielsen, Annick Ménétrey, David R. Cameron et autres

0 citationsAntimicrobial Agents and Chemotherapy

Accès ouvert 2026 articleOpenAlex

Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [ 14 C]Xevinapant, a Potent, Oral, Small‐Molecule IAP Inhibitor

Annick Ménétrey, Valerie Nicolas‐Métral, Marie-Claude Roubaudi-Fraschini, Tri Tat et autres

0 citationsClinical Pharmacology in Drug Development

Accès ouvert 2025 articleOpenAlex

P-1229. Assessment of Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment for the Anti-Staphylococcal Antibiotic Afabicin

David R. Cameron, Christopher M. Rubino, Annick Ménétrey, Anthony P Cammarata et autres

2 citationsOpen Forum Infectious Diseases

Accès ouvert 2024 articleOpenAlex

Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus

R. Saporta, Elisabet I. Nielsen, Annick Ménétrey, David R. Cameron et autres

7 citationsJournal of Antimicrobial Chemotherapy

2024 conference-abstractOpenAlex

Abstract CT140: A phase 1 study of the IAP inhibitor xevinapant (Debio 1143) to evaluate food effect and drug-drug interactions with a proton pump inhibitor in healthy volunteers

Valerie Nicolas‐Métral, Elisabeth Rouits, Camille Riff, Dany Spaggiari et autres

0 citationsCancer Research

2024 conference-abstractOpenAlex

Abstract CT064: Impact of food and high gastric pH on the bioavailability of the WEE1 inhibitor Debio 0123 assessed in a phase 1 dose escalation study

Anne Bellon, Omar Saavedra, Ingrid M.E. Desar, Mathilde Jalving et autres

0 citationsCancer Research

Accès ouvert 2023 articleOpenAlex

Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin

Justyna Nowakowska, David R. Cameron, A De Martino, Joachim Kühn et autres

10 citationsJournal of Antimicrobial Chemotherapy

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations

Martin H. Voss, Cinta Hierro, Rebecca S. Heist, James M. Cleary et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations

Martin H. Voss, Cinta Hierro, Rebecca S. Heist, James M. Cleary et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations

Martin H. Voss, Cinta Hierro, Rebecca S. Heist, James M. Cleary et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations

Martin H. Voss, Cinta Hierro, Rebecca S. Heist, James M. Cleary et autres

0 citations

2020 conference-abstractOpenAlex

Final results from the phase I study expansion cohort of the selective FGFR inhibitor Debio 1,347 in patients with solid tumors harboring an FGFR gene fusion.

James M. Cleary, Gopa Iyer, Do‐Youn Oh, Ingo K. Mellinghoff et autres

34 citationsJournal of Clinical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.